Collaborative AI Models for Drug Discovery

Basecamp Research Unveils Trillion Gene Atlas for AI

New genomic catalog of 100 million species aims to accelerate AI-driven therapeutic design.

By Avantgarde News Desk··1 min read
A digital display showing complex 3D DNA models and interconnected neural network nodes, representing the intersection of genomics and artificial intelligence.

A digital display showing complex 3D DNA models and interconnected neural network nodes, representing the intersection of genomics and artificial intelligence.

Photo: Avantgarde News

Basecamp Research announced the launch of the Trillion Gene Atlas to scale AI-designed therapeutics [1][2]. This initiative aims to catalog genomic data from more than 100 million species across the globe [1][3]. The massive dataset provides a foundation for training advanced AI models to identify new drug targets [2]. Basecamp Research is collaborating with technology leaders Anthropic and NVIDIA on the project [2][3]. These partnerships focus on training large-scale models for programmable biological design [1]. The goal is to create more precise treatments by leveraging a wider range of genetic diversity [3]. The atlas seeks to overcome limitations in current genomic databases by including diverse environmental samples [1][3]. This expansion could significantly improve the speed of drug discovery processes [2]. Details regarding specific therapeutic candidates were not confirmed in the available sources.

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Minimal

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers collaborative ai models for drug discovery and editorial analysis for Avantgarde News.